These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 28912673)
1. Improving the Delivery of SOD1 Antisense Oligonucleotides to Motor Neurons Using Calcium Phosphate-Lipid Nanoparticles. Chen L; Watson C; Morsch M; Cole NJ; Chung RS; Saunders DN; Yerbury JJ; Vine KL Front Neurosci; 2017; 11():476. PubMed ID: 28912673 [TBL] [Abstract][Full Text] [Related]
2. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487 [TBL] [Abstract][Full Text] [Related]
4. Antisense Oligonucleotides for the Study and Treatment of ALS. Boros BD; Schoch KM; Kreple CJ; Miller TM Neurotherapeutics; 2022 Jul; 19(4):1145-1158. PubMed ID: 35653060 [TBL] [Abstract][Full Text] [Related]
5. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940 [TBL] [Abstract][Full Text] [Related]
6. Early upregulation of cytosolic phospholipase A Malada Edelstein YF; Solomonov Y; Hadad N; Alfahel L; Israelson A; Levy R J Neuroinflammation; 2021 Nov; 18(1):274. PubMed ID: 34823547 [TBL] [Abstract][Full Text] [Related]
7. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival. Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995 [TBL] [Abstract][Full Text] [Related]
11. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice. Gertz B; Wong M; Martin LJ J Neuropathol Exp Neurol; 2012 Feb; 71(2):162-77. PubMed ID: 22249462 [TBL] [Abstract][Full Text] [Related]
12. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1 Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622 [TBL] [Abstract][Full Text] [Related]
13. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue. Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962 [TBL] [Abstract][Full Text] [Related]
14. Targeted ASO-mediated Atp1a2 knockdown in astrocytes reduces SOD1 aggregation and accelerates disease onset in mutant SOD1 mice. Iyer AK; Schoch KM; Verbeck A; Galasso G; Chen H; Smith S; Oldenborg A; Miller TM; Karch CM; Bonni A PLoS One; 2023; 18(11):e0294731. PubMed ID: 38015828 [TBL] [Abstract][Full Text] [Related]
15. Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression. Perera ND; Sheean RK; Lau CL; Shin YS; Beart PM; Horne MK; Turner BJ Autophagy; 2018; 14(3):534-551. PubMed ID: 28980850 [TBL] [Abstract][Full Text] [Related]
16. Silencing strategies for therapy of SOD1-mediated ALS. van Zundert B; Brown RH Neurosci Lett; 2017 Jan; 636():32-39. PubMed ID: 27507699 [TBL] [Abstract][Full Text] [Related]